Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis - PubMed (original) (raw)
Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis
Manuela G Neuman et al. J Viral Hepat. 2002 Mar.
Abstract
Our aims were to measure the kinetics of serum tumour necrosis alpha (TNF-alpha) and transforming growth factor beta (TGF-beta) levels as markers of progression of disease in nontreated chronic hepatitis C virus (HCV)-infected patients with minimal or no fibrosis and minimal histology activity index (HAI) scores. Our study group consisted of 56 patients diagnosed with minimal (1) or no fibrosis (0) and minimal HAI (0-1) on their first biopsy as defined by Knodell and METAVIR scores. We compared their initial (entry of study) cytokine levels with a group of 103 HCV controls with minimal (0-1) to mild fibrosis (0-3) and mild HAI (5.5). Serum TNF-alpha and TGF-beta levels were measured by enzyme-linked-immunosorbent-assay. A significant difference was seen in TNF-alpha levels at baseline in the study group vs. controls. Regardless of their HAI, there was a correlation between TGF-beta and degree of fibrosis. As shown by their biopsies, during the 3 years (from entry to follow up), many of the patients that initially had minimal fibrosis progressed to higher degree of fibrosis. This progression is paralleled by an increase in TGF-beta levels when comparing initial and follow-up levels. In conclusion, serum TNF-alpha reflects the progression of inflammation as seen in liver biopsies and TGF-beta reflects the degree of fibrosis in HCV patients.
Similar articles
- Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapy.
Neuman MG, Benhamou JP, Bourliere M, Ibrahim A, Malkiewicz I, Asselah T, Martinot-Peignoux M, Shear NH, Katz GG, Akremi R, Benali S, Boyer N, Lecomte L, Le Breton V, Le Guludec G, Marcellin P. Neuman MG, et al. Cytokine. 2002 Jan 21;17(2):108-17. doi: 10.1006/cyto.2001.0997. Cytokine. 2002. PMID: 11886178 Clinical Trial. - Cytokine levels and histopathology in chronic hepatitis B and chronic hepatitis C.
Akcam FZ, Tigli A, Kaya O, Ciris M, Vural H. Akcam FZ, et al. J Interferon Cytokine Res. 2012 Dec;32(12):570-4. doi: 10.1089/jir.2012.0048. Epub 2012 Oct 15. J Interferon Cytokine Res. 2012. PMID: 23067363 Clinical Trial. - Cytokine--chemokine and apoptotic signatures in patients with hepatitis C.
Neuman MG, Benhamou JP, Marcellin P, Valla D, Malkiewicz IM, Katz GG, Trepo C, Bourliere M, Cameron RG, Cohen L, Morgan M, Schmilovitz-Weiss H, Ben-Ari Z. Neuman MG, et al. Transl Res. 2007 Mar;149(3):126-36. doi: 10.1016/j.trsl.2006.11.002. Transl Res. 2007. PMID: 17320798 - Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta.
Kanzler S, Baumann M, Schirmacher P, Dries V, Bayer E, Gerken G, Dienes HP, Lohse AW. Kanzler S, et al. J Viral Hepat. 2001 Nov;8(6):430-7. doi: 10.1046/j.1365-2893.2001.00314.x. J Viral Hepat. 2001. PMID: 11703574 - [Histological characteristics of chronic hepatitis C in biopsy material].
Jármay K, Karácsony G, Ozsvár Z, Nagy I, Schaff Z, Lonovics J. Jármay K, et al. Orv Hetil. 1998 Aug 16;139(33):1955-60. Orv Hetil. 1998. PMID: 9734212 Review. Hungarian.
Cited by
- Inflammation and repair in viral hepatitis C.
Neuman MG, Sha K, Esguerra R, Zakhari S, Winkler RE, Hilzenrat N, Wyse J, Cooper CL, Seth D, Gorrell MD, Haber PS, McCaughan GW, Leo MA, Lieber CS, Voiculescu M, Buzatu E, Ionescu C, Dudas J, Saile B, Ramadori G. Neuman MG, et al. Dig Dis Sci. 2008 Jun;53(6):1468-87. doi: 10.1007/s10620-007-0047-3. Dig Dis Sci. 2008. PMID: 17994278 Review. - Acute and chronic immune biomarker changes during interferon/ribavirin treatment in HIV/HCV co-infected patients.
Jain MK, Adams-Huet B, Terekhova D, Kushner LE, Bedimo R, Li X, Holodniy M. Jain MK, et al. J Viral Hepat. 2015 Jan;22(1):25-36. doi: 10.1111/jvh.12226. Epub 2014 Feb 9. J Viral Hepat. 2015. PMID: 24506344 Free PMC article. - Clinical significance and functional studies of myeloid-derived suppressor cells in chronic hepatitis C patients.
Cai W, Qin A, Guo P, Yan D, Hu F, Yang Q, Xu M, Fu Y, Zhou J, Tang X. Cai W, et al. J Clin Immunol. 2013 May;33(4):798-808. doi: 10.1007/s10875-012-9861-2. Epub 2013 Jan 26. J Clin Immunol. 2013. PMID: 23354838 - Inflammation and Liver Cell Death in Patients with Hepatitis C Viral Infection.
Neuman MG, Cohen LB. Neuman MG, et al. Curr Issues Mol Biol. 2021 Nov 16;43(3):2022-2035. doi: 10.3390/cimb43030139. Curr Issues Mol Biol. 2021. PMID: 34889885 Free PMC article. - Single-dose infliximab in hepatitis C genotype 1 treatment-naive patients with high serum tumour necrosis factor-alpha does not influence the efficacy of pegylated interferon alpha-2b/ribavirin therapy.
Cooper C, Shafran S, Greenbloom S, Enns R, Farley J, Hilzenrat N, Williams K, Elkashab M, Abadir N, Neuman M. Cooper C, et al. Can J Gastroenterol Hepatol. 2014 Jan;28(1):35-40. doi: 10.1155/2014/367131. Epub 2013 Nov 8. Can J Gastroenterol Hepatol. 2014. PMID: 24212915 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials